{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T23:53:17Z","timestamp":1793922797973,"version":"4.8.0"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,2,25]],"date-time":"2022-02-25T00:00:00Z","timestamp":1645747200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,2,25]],"date-time":"2022-02-25T00:00:00Z","timestamp":1645747200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81802669"],"award-info":[{"award-number":["81802669"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["61871294"],"award-info":[{"award-number":["61871294"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81472046 and 81772299"],"award-info":[{"award-number":["81472046 and 81772299"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81501852 and 82072391"],"award-info":[{"award-number":["81501852 and 82072391"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004826","name":"Natural Science Foundation of Beijing Municipality","doi-asserted-by":"publisher","award":["JQ20032"],"award-info":[{"award-number":["JQ20032"]}],"id":[{"id":"10.13039\/501100004826","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Tsinghua University-Peking Union Medical College Hospital Initiative Scientific Research Program"},{"name":"the PUMC Youth Fund & the Fundamental Research Funds for the Central Universities","award":["No.3332019052"],"award-info":[{"award-number":["No.3332019052"]}]},{"DOI":"10.13039\/501100004731","name":"Natural Science Foundation of Zhejiang Province","doi-asserted-by":"publisher","award":["LR19C060001"],"award-info":[{"award-number":["LR19C060001"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Fundamental Research Funds for Wenzhou Institute of University of Chinese Academy of Sciences","award":["WIBEZD2017009-05"],"award-info":[{"award-number":["WIBEZD2017009-05"]}]},{"name":"the CAMS Innovation Fund for Medical Sciences","award":["2020-I2M-C&T-B-068"],"award-info":[{"award-number":["2020-I2M-C&T-B-068"]}]},{"name":"the CAMS Innovation Fund for Medical Sciences","award":["2020-I2M-C&T-A-015"],"award-info":[{"award-number":["2020-I2M-C&T-A-015"]}]},{"name":"the CAMS Innovation Fund for Medical Sciences","award":["2021-I2M-1-051"],"award-info":[{"award-number":["2021-I2M-1-051"]}]},{"name":"the CAMS Innovation Fund for Medical Sciences","award":["2021-I2M-1-052"],"award-info":[{"award-number":["2021-I2M-1-052"]}]},{"name":"the Beijing Hope Run Special Fund","award":["LC2020B05"],"award-info":[{"award-number":["LC2020B05"]}]},{"name":"Non-profit Central Research Institute Fund of Chinese Academy of Medical Sciences","award":["2019PT320025"],"award-info":[{"award-number":["2019PT320025"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Genome Med"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Identifying breast cancer patients with DNA repair pathway-related germline pathogenic variants (GPVs) is important for effectively employing systemic treatment strategies and risk-reducing interventions. However, current criteria and risk prediction models for prioritizing genetic testing among breast cancer patients do not meet the demands of clinical practice due to insufficient accuracy.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>The study population comprised 3041 breast cancer patients enrolled from seven hospitals between October 2017 and 11 August 2019, who underwent germline genetic testing of 50 cancer predisposition genes (CPGs). Associations among GPVs in different CPGs and endophenotypes were evaluated using a case-control analysis. A phenotype-based GPV risk prediction model named DNA-repair Associated Breast Cancer (DrABC) was developed based on hierarchical neural network architecture and validated in an independent multicenter cohort. The predictive performance of DrABC was compared with currently used models including BRCAPRO, BOADICEA, Myriad, PENN II, and the NCCN criteria.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>In total, 332 (11.3%) patients harbored GPVs in CPGs, including 134 (4.6%) in <jats:italic>BRCA2<\/jats:italic>, 131 (4.5%) in <jats:italic>BRCA1<\/jats:italic>, 33 (1.1%) in <jats:italic>PALB2<\/jats:italic>, and 37 (1.3%) in other CPGs. GPVs in CPGs were associated with distinct endophenotypes including the age at diagnosis, cancer history, family cancer history, and pathological characteristics. We developed a DrABC model to predict the risk of GPV carrier status in <jats:italic>BRCA1\/2<\/jats:italic> and other important CPGs. In predicting GPVs in <jats:italic>BRCA1\/2<\/jats:italic>, the performance of DrABC (AUC = 0.79 [95% CI, 0.74\u20130.85], sensitivity = 82.1%, specificity = 63.1% in the independent validation cohort) was better than that of previous models (AUC range = 0.57\u20130.70). In predicting GPVs in any CPG, DrABC (AUC = 0.74 [95% CI, 0.69\u20130.79], sensitivity = 83.8%, specificity = 51.3% in the independent validation cohort) was also superior to previous models in their current versions (AUC range = 0.55\u20130.65). After training these previous models with the Chinese-specific dataset, DrABC still outperformed all other methods except for BOADICEA, which was the only previous model with the inclusion of pathological features. The DrABC model also showed higher sensitivity and specificity than the NCCN criteria in the multi-center validation cohort (83.8% and 51.3% vs. 78.8% and 31.2%, respectively, in predicting GPVs in any CPG). The DrABC model implementation is available online at <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/gifts.bio-data.cn\/\">http:\/\/gifts.bio-data.cn\/<\/jats:ext-link>.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>By considering the distinct endophenotypes associated with different CPGs in breast cancer patients, a phenotype-driven prediction model based on hierarchical neural network architecture was created for identification of hereditary breast cancer. The model achieved superior performance in identifying GPV carriers among Chinese breast cancer patients.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13073-022-01027-9","type":"journal-article","created":{"date-parts":[[2022,2,25]],"date-time":"2022-02-25T00:02:47Z","timestamp":1645747367000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["DrABC: deep learning accurately predicts germline pathogenic mutation status in breast cancer patients based on phenotype data"],"prefix":"10.1186","volume":"14","author":[{"given":"Jiaqi","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hengqiang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sen","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukuan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengkai","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianyi","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiali","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zihui","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yalun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenyan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiqun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Ming","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeyu","family":"Xing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengye","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziqi","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaxin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Menglu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kexin","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianguo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongxin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihua","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianming","family":"Ying","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianzhong","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9429-2889","authenticated-orcid":false,"given":"Nan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,2,25]]},"reference":[{"issue":"10","key":"1027_CR1","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1001\/jamaoncol.2019.0620","volume":"5","author":"YS Yap","year":"2019","unstructured":"Yap YS, Lu YS, Tamura K, Lee JE, Ko EY, Park YH, et al. Insights into breast cancer in the east vs the west: a review. JAMA Oncol. 2019;5(10):1489\u201396.","journal-title":"JAMA Oncol"},{"issue":"15","key":"1027_CR2","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1200\/JCO.18.01854","volume":"37","author":"AW Kurian","year":"2019","unstructured":"Kurian AW, Ward KC, Howlader N, Deapen D, Hamilton AS, Mariotto A, et al. Genetic testing and results in a population-based cohort of breast cancer patients and ovarian cancer patients. J Clin Oncol. 2019;37(15):1305\u201315.","journal-title":"J Clin Oncol"},{"issue":"25","key":"1027_CR3","doi-asserted-by":"publisher","first-page":"2490","DOI":"10.1056\/NEJMcibr1710161","volume":"377","author":"NC Turner","year":"2017","unstructured":"Turner NC. Signatures of DNA-repair deficiencies in breast cancer. N Engl J Med. 2017;377(25):2490\u20132.","journal-title":"N Engl J Med"},{"issue":"2","key":"1027_CR4","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1001\/jamaoncol.2016.2719","volume":"3","author":"P Niravath","year":"2017","unstructured":"Niravath P, Cakar B, Ellis M. The role of genetic testing in the selection of therapy for breast cancer: a review. JAMA Oncol. 2017;3(2):262\u20138.","journal-title":"JAMA Oncol"},{"issue":"1","key":"1027_CR5","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s13073-019-0680-4","volume":"11","author":"B Tutuncuoglu","year":"2019","unstructured":"Tutuncuoglu B, Krogan NJ. Mapping genetic interactions in cancer: a road to rational combination therapies. Genome Med. 2019;11(1):62.","journal-title":"Genome Med"},{"issue":"6","key":"1027_CR6","doi-asserted-by":"publisher","first-page":"1732","DOI":"10.1245\/s10434-012-2257-y","volume":"19","author":"B Drohan","year":"2012","unstructured":"Drohan B, Roche CA, Cusack JC Jr, Hughes KS. Hereditary breast and ovarian cancer and other hereditary syndromes: using technology to identify carriers. Ann Surg Oncol. 2012;19(6):1732\u20137.","journal-title":"Ann Surg Oncol"},{"issue":"6","key":"1027_CR7","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1200\/JCO.18.01631","volume":"37","author":"PD Beitsch","year":"2019","unstructured":"Beitsch PD, Whitworth PW, Hughes K, Patel R, Rosen B, Compagnoni G, et al. Underdiagnosis of hereditary breast cancer: are genetic testing guidelines a tool or an obstacle? J Clin Oncol. 2019;37(6):453\u201360.","journal-title":"J Clin Oncol"},{"issue":"23","key":"1027_CR8","doi-asserted-by":"publisher","first-page":"2587","DOI":"10.1001\/jama.297.23.2587","volume":"297","author":"JN Weitzel","year":"2007","unstructured":"Weitzel JN, Lagos VI, Cullinane CA, Gambol PJ, Culver JO, Blazer KR, et al. Limited family structure and BRCA gene mutation status in single cases of breast cancer. JAMA. 2007;297(23):2587\u201395.","journal-title":"JAMA."},{"issue":"3","key":"1027_CR9","doi-asserted-by":"publisher","first-page":"R28","DOI":"10.1186\/bcr2576","volume":"12","author":"N Mavaddat","year":"2010","unstructured":"Mavaddat N, Rebbeck TR, Lakhani SR, Easton DF, Antoniou AC. Incorporating tumour pathology information into breast cancer risk prediction algorithms. Breast Cancer Res. 2010;12(3):R28.","journal-title":"Breast Cancer Res"},{"issue":"10","key":"1027_CR10","doi-asserted-by":"publisher","first-page":"3025","DOI":"10.1245\/s10434-019-07549-8","volume":"26","author":"ER Manahan","year":"2019","unstructured":"Manahan ER, Kuerer HM, Sebastian M, Hughes KS, Boughey JC, Euhus DM, et al. Consensus guidelines on genetic testing for hereditary breast cancer from the American Society of Breast Surgeons. Ann Surg Oncol. 2019;26(10):3025\u201331.","journal-title":"Ann Surg Oncol"},{"issue":"10","key":"1027_CR11","doi-asserted-by":"publisher","first-page":"2925","DOI":"10.1245\/s10434-018-6621-4","volume":"25","author":"S Yang","year":"2018","unstructured":"Yang S, Axilbund JE, O'Leary E, Michalski ST, Evans R, Lincoln SE, et al. Underdiagnosis of hereditary breast and ovarian cancer in medicare patients: genetic testing criteria miss the mark. Ann Surg Oncol. 2018;25(10):2925\u201331.","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"1027_CR12","doi-asserted-by":"publisher","first-page":"380","DOI":"10.6004\/jnccn.2020.0017","volume":"18","author":"MB Daly","year":"2020","unstructured":"Daly MB, Pilarski R, Yurgelun MB, Berry MP, Buys SS, Dickson P, et al. NCCN guidelines insights: genetic\/familial high-risk assessment: breast, ovarian, and pancreatic, version 1.2020. J Natl Compr Cancer Netw. 2020;18(4):380\u201391.","journal-title":"J Natl Compr Cancer Netw"},{"issue":"13","key":"1027_CR13","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1200\/JCO.19.02190","volume":"38","author":"S Yadav","year":"2020","unstructured":"Yadav S, Hu C, Hart SN, Boddicker N, Polley EC, Na J, et al. Evaluation of germline genetic testing criteria in a hospital-based series of women with breast cancer. J Clin Oncol. 2020;38(13):1409\u201318.","journal-title":"J Clin Oncol"},{"issue":"6","key":"1027_CR14","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1200\/JCO.18.01952","volume":"37","author":"KJ Milliron","year":"2019","unstructured":"Milliron KJ, Griggs JJ. Advances in genetic testing in patients with breast cancer, high-quality decision making, and responsible resource allocation. J Clin Oncol. 2019;37(6):445\u20137.","journal-title":"J Clin Oncol"},{"issue":"1","key":"1027_CR15","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/nrclinonc.2015.173","volume":"13","author":"WD Foulkes","year":"2016","unstructured":"Foulkes WD, Knoppers BM, Turnbull C. Population genetic testing for cancer susceptibility: founder mutations to genomes. Nat Rev Clin Oncol. 2016;13(1):41\u201354.","journal-title":"Nat Rev Clin Oncol"},{"issue":"1","key":"1027_CR16","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/s10549-019-05228-6","volume":"176","author":"R Bernstein-Molho","year":"2019","unstructured":"Bernstein-Molho R, Singer A, Laitman Y, Netzer I, Zalmanoviz S, Friedman E. Multigene panel testing in unselected Israeli breast cancer cases: mutational spectrum and use of BRCA1\/2 mutation prediction algorithms. Breast Cancer Res Treat. 2019;176(1):165\u201370.","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"1027_CR17","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/s13073-019-0689-8","volume":"11","author":"R Dias","year":"2019","unstructured":"Dias R, Torkamani A. Artificial intelligence in clinical and genomic diagnostics. Genome Med. 2019;11(1):70.","journal-title":"Genome Med"},{"key":"1027_CR18","doi-asserted-by":"publisher","first-page":"661109","DOI":"10.3389\/fgene.2021.661109","volume":"12","author":"X Wang","year":"2021","unstructured":"Wang X, Zou C, Zhang Y, Li X, Wang C, Ke F, et al. Prediction of BRCA gene mutation in breast cancer based on deep learning and histopathology images. Front Genet. 2021;12:661109.","journal-title":"Front Genet"},{"issue":"1","key":"1027_CR19","doi-asserted-by":"publisher","first-page":"16511","DOI":"10.1038\/s41598-020-73505-2","volume":"10","author":"C Nero","year":"2020","unstructured":"Nero C, Ciccarone F, Boldrini L, Lenkowicz J, Paris I, Capoluongo ED, et al. Germline BRCA1-2 status prediction through ovarian ultrasound images radiogenomics: a hypothesis generating study (PROBE study). Sci Rep. 2020;10(1):16511.","journal-title":"Sci Rep"},{"key":"1027_CR20","doi-asserted-by":"publisher","first-page":"103033","DOI":"10.1016\/j.ebiom.2020.103033","volume":"60","author":"K Mizukami","year":"2020","unstructured":"Mizukami K, Iwasaki Y, Kawakami E, Hirata M, Kamatani Y, Matsuda K, et al. Genetic characterization of pancreatic cancer patients and prediction of carrier status of germline pathogenic variants in cancer-predisposing genes. EBioMedicine. 2020;60:103033.","journal-title":"EBioMedicine."},{"issue":"8","key":"1027_CR21","doi-asserted-by":"publisher","first-page":"573","DOI":"10.7326\/0003-4819-147-8-200710160-00010","volume":"147","author":"E von Elm","year":"2007","unstructured":"von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP, et al. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. Ann Intern Med. 2007;147(8):573\u20137.","journal-title":"Ann Intern Med"},{"issue":"8","key":"1027_CR22","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.1093\/annonc\/mdx308","volume":"28","author":"G Curigliano","year":"2017","unstructured":"Curigliano G, Burstein HJ, Winer EP, Gnant M, Dubsky P, Loibl S, et al. De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen international expert consensus conference on the primary therapy of early breast cancer 2017. Ann Oncol. 2017;28(8):1700\u201312.","journal-title":"Ann Oncol"},{"key":"1027_CR23","volume-title":"AJCC cancer staging manual","author":"American Joint Committee on Cancer (AJCC)","year":"2017","unstructured":"American Joint Committee on Cancer (AJCC). AJCC cancer staging manual. 8th ed. New York: Springer; 2017.","edition":"8"},{"issue":"10","key":"1027_CR24","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1136\/jmedgenet-2017-105224","volume":"55","author":"K Wang","year":"2018","unstructured":"Wang K, Zhao S, Liu B, Zhang Q, Li Y, Liu J, et al. Perturbations of BMP\/TGF-beta and VEGF\/VEGFR signalling pathways in non-syndromic sporadic brain arteriovenous malformations (BAVM). J Med Genet. 2018;55(10):675\u201384.","journal-title":"J Med Genet"},{"issue":"1","key":"1027_CR25","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1136\/jmedgenet-2019-106823","volume":"58","author":"S Zhao","year":"2021","unstructured":"Zhao S, Zhang Y, Chen W, Li W, Wang S, Wang L, et al. Diagnostic yield and clinical impact of exome sequencing in early-onset scoliosis (EOS). J Med Genet. 2021;58(1):41\u20137.","journal-title":"J Med Genet"},{"issue":"5","key":"1027_CR26","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17(5):405\u201324.","journal-title":"Genet Med"},{"issue":"2","key":"1027_CR27","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.ajhg.2017.01.004","volume":"100","author":"Q Li","year":"2017","unstructured":"Li Q, Wang K. InterVar: clinical interpretation of genetic variants by the 2015 ACMG-AMP guidelines. Am J Hum Genet. 2017;100(2):267\u201380.","journal-title":"Am J Hum Genet"},{"issue":"1","key":"1027_CR28","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s13073-019-0687-x","volume":"11","author":"AM Danos","year":"2019","unstructured":"Danos AM, Krysiak K, Barnell EK, Coffman AC, McMichael JF, Kiwala S, et al. Standard operating procedure for curation and clinical interpretation of variants in cancer. Genome Med. 2019;11(1):76.","journal-title":"Genome Med"},{"issue":"10","key":"1027_CR29","doi-asserted-by":"publisher","first-page":"2057","DOI":"10.1093\/annonc\/mdv278","volume":"26","author":"DM Eccles","year":"2015","unstructured":"Eccles DM, Mitchell G, Monteiro AN, Schmutzler R, Couch FJ, Spurdle AB, et al. BRCA1 and BRCA2 genetic testing-pitfalls and recommendations for managing variants of uncertain clinical significance. Ann Oncol. 2015;26(10):2057\u201365.","journal-title":"Ann Oncol"},{"issue":"1","key":"1027_CR30","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1002\/humu.21628","volume":"33","author":"AB Spurdle","year":"2012","unstructured":"Spurdle AB, Healey S, Devereau A, Hogervorst FB, Monteiro AN, Nathanson KL, et al. ENIGMA--evidence-based network for the interpretation of germline mutant alleles: an international initiative to evaluate risk and clinical significance associated with sequence variation in BRCA1 and BRCA2 genes. Hum Mutat. 2012;33(1):2\u20137.","journal-title":"Hum Mutat"},{"key":"1027_CR31","first-page":"972","volume-title":"Proceedings of the 31st international conference on neural information processing systems","author":"G Klambauer","year":"2017","unstructured":"Klambauer G, Unterthiner T, Mayr A, Hochreiter S. Self-normalizing neural networks. In:  Proceedings of the 31st international conference on neural information processing systems; 2017. p. 972\u201381. URL: https:\/\/proceedings.neurips.cc\/paper\/2017\/file\/5d44ee6f2c3f71b73125876103c8f6c4-Paper.pdf."},{"issue":"3","key":"1027_CR32","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1158\/1078-0432.1146.11.3","volume":"11","author":"S Alvarez","year":"2005","unstructured":"Alvarez S, Diaz-Uriarte R, Osorio A, Barroso A, Melchor L, Paz MF, et al. A predictor based on the somatic genomic changes of the BRCA1\/BRCA2 breast cancer tumors identifies the non-BRCA1\/BRCA2 tumors with BRCA1 promoter hypermethylation. Clin Cancer Res. 2005;11(3):1146\u201353.","journal-title":"Clin Cancer Res"},{"issue":"1","key":"1027_CR33","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1023\/A:1010933404324","volume":"45","author":"L Breiman","year":"2001","unstructured":"Breiman L. Random forests. Mach Learn. 2001;45(1):5\u201332.","journal-title":"Mach Learn"},{"key":"1027_CR34","volume-title":"Proceedings of the AutoML workshop at ICML","author":"E LeDell","year":"2020","unstructured":"LeDell E, Poirier S. H2o automl: scalable automatic machine learning. In:  Proceedings of the AutoML workshop at ICML; 2020. URL: https:\/\/www.automl.org\/wp-content\/uploads\/2020\/07\/AutoML_2020_paper_61.pdf."},{"issue":"Suppl 2","key":"1027_CR35","first-page":"147","volume":"14","author":"E Mazzola","year":"2015","unstructured":"Mazzola E, Blackford A, Parmigiani G, Biswas S. Recent enhancements to the genetic risk prediction model BRCAPRO. Cancer Informat. 2015;14(Suppl 2):147\u201357.","journal-title":"Cancer Informat"},{"issue":"20","key":"1027_CR36","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1093\/jnci\/94.20.1582","volume":"94","author":"V Bonadona","year":"2002","unstructured":"Bonadona V, Sinilnikova OM, Lenoir GM, Lasset C. Pretest prediction of BRCA1 or BRCA2 mutation by risk counselors and the computer model BRCAPRO. J Natl Cancer Inst. 2002;94(20):1582\u20133 author reply 3-4.","journal-title":"J Natl Cancer Inst"},{"issue":"6","key":"1027_CR37","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1200\/JCO.2002.20.6.1480","volume":"20","author":"TS Frank","year":"2002","unstructured":"Frank TS, Deffenbaugh AM, Reid JE, Hulick M, Ward BE, Lingenfelter B, et al. Clinical characteristics of individuals with germline mutations in BRCA1 and BRCA2: analysis of 10,000 individuals. J Clin Oncol. 2002;20(6):1480\u201390.","journal-title":"J Clin Oncol"},{"issue":"4","key":"1027_CR38","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1007\/s10689-010-9348-3","volume":"9","author":"NM Lindor","year":"2010","unstructured":"Lindor NM, Johnson KJ, Harvey H, Shane Pankratz V, Domchek SM, Hunt K, et al. Predicting BRCA1 and BRCA2 gene mutation carriers: comparison of PENN II model to previous study. Familial Cancer. 2010;9(4):495\u2013502.","journal-title":"Familial Cancer"},{"issue":"8","key":"1027_CR39","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1038\/s41436-018-0406-9","volume":"21","author":"A Lee","year":"2019","unstructured":"Lee A, Mavaddat N, Wilcox AN, Cunningham AP, Carver T, Hartley S, et al. BOADICEA: a comprehensive breast cancer risk prediction model incorporating genetic and nongenetic risk factors. Genet Med. 2019;21(8):1708\u201318.","journal-title":"Genet Med"},{"issue":"3","key":"1027_CR40","doi-asserted-by":"publisher","first-page":"837","DOI":"10.2307\/2531595","volume":"44","author":"ER DeLong","year":"1988","unstructured":"DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics. 1988;44(3):837\u201345.","journal-title":"Biometrics."},{"issue":"11","key":"1027_CR41","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1109\/LSP.2014.2337313","volume":"21","author":"X Sun","year":"2014","unstructured":"Sun X, Xu W. Fast implementation of DeLong\u2019s algorithm for comparing the areas under correlated receiver operating characteristic curves. IEEE Signal Proc Lett. 2014;21(11):1389\u201393.","journal-title":"IEEE Signal Proc Lett"},{"issue":"16","key":"1027_CR42","doi-asserted-by":"publisher","first-page":"2115","DOI":"10.1002\/1097-0258(20000830)19:16<2115::AID-SIM529>3.0.CO;2-M","volume":"19","author":"B Reiser","year":"2000","unstructured":"Reiser B. Measuring the effectiveness of diagnostic markers in the presence of measurement error through the use of ROC curves. Stat Med. 2000;19(16):2115\u201329.","journal-title":"Stat Med"},{"key":"1027_CR43","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.breast.2017.07.017","volume":"35","author":"S Paluch-Shimon","year":"2017","unstructured":"Paluch-Shimon S, Pagani O, Partridge AH, Abulkhair O, Cardoso MJ, Dent RA, et al. ESO-ESMO 3rd international consensus guidelines for breast cancer in young women (BCY3). Breast. 2017;35:203\u201317.","journal-title":"Breast."},{"key":"1027_CR44","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1146\/annurev-biochem-013118-111058","volume":"88","author":"W Zhao","year":"2019","unstructured":"Zhao W, Wiese C, Kwon Y, Hromas R, Sung P. The BRCA tumor suppressor network in chromosome damage repair by homologous recombination. Annu Rev Biochem. 2019;88:221\u201345.","journal-title":"Annu Rev Biochem"},{"issue":"9","key":"1027_CR45","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1001\/jamaoncol.2017.0424","volume":"3","author":"FJ Couch","year":"2017","unstructured":"Couch FJ, Shimelis H, Hu C, Hart SN, Polley EC, Na J, et al. Associations between cancer predisposition testing panel genes and breast cancer. JAMA Oncol. 2017;3(9):1190\u20136.","journal-title":"JAMA Oncol"},{"issue":"12","key":"1027_CR46","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1186\/s13073-014-0121-3","volume":"6","author":"JY Cheon","year":"2014","unstructured":"Cheon JY, Mozersky J, Cook-Deegan R. Variants of uncertain significance in BRCA: a harbinger of ethical and policy issues to come? Genome Med. 2014;6(12):121.","journal-title":"Genome Med"},{"issue":"2","key":"1027_CR47","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1038\/bjc.2013.730","volume":"110","author":"AJ Lee","year":"2014","unstructured":"Lee AJ, Cunningham AP, Kuchenbaecker KB, Mavaddat N, Easton DF, Antoniou AC, et al. BOADICEA breast cancer risk prediction model: updates to cancer incidences, tumour pathology and web interface. Br J Cancer. 2014;110(2):535\u201345.","journal-title":"Br J Cancer"},{"key":"1027_CR48","doi-asserted-by":"crossref","unstructured":"Kurian AW, Ward KC, Abrahamse P, Hamilton AS, Deapen D, Morrow M, et al. Association of germline genetic testing results with locoregional and systemic therapy in patients with breast cancer. JAMA Oncol. 2020;6(4):e196400.","DOI":"10.1001\/jamaoncol.2019.6400"},{"issue":"1","key":"1027_CR49","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.ygyno.2017.01.026","volume":"145","author":"KJ Eoh","year":"2017","unstructured":"Eoh KJ, Park JS, Park HS, Lee ST, Han J, Lee JY, et al. BRCA1 and BRCA2 mutation predictions using the BRCAPRO and myriad models in Korean ovarian cancer patients. Gynecol Oncol. 2017;145(1):137\u201341.","journal-title":"Gynecol Oncol"},{"issue":"4","key":"1027_CR50","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1200\/JCO.2005.01.9737","volume":"24","author":"PA James","year":"2006","unstructured":"James PA, Doherty R, Harris M, Mukesh BN, Milner A, Young MA, et al. Optimal selection of individuals for BRCA mutation testing: a comparison of available methods. J Clin Oncol. 2006;24(4):707\u201315.","journal-title":"J Clin Oncol"},{"issue":"3","key":"1027_CR51","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1200\/JCO.2005.02.2368","volume":"24","author":"CH Barcenas","year":"2006","unstructured":"Barcenas CH, Hosain GM, Arun B, Zong J, Zhou X, Chen J, et al. Assessing BRCA carrier probabilities in extended families. J Clin Oncol. 2006;24(3):354\u201360.","journal-title":"J Clin Oncol"},{"issue":"1","key":"1027_CR52","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.cell.2011.09.008","volume":"147","author":"JR Lupski","year":"2011","unstructured":"Lupski JR, Belmont JW, Boerwinkle E, Gibbs RA. Clan genomics and the complex architecture of human disease. Cell. 2011;147(1):32\u201343.","journal-title":"Cell."},{"issue":"1","key":"1027_CR53","doi-asserted-by":"publisher","first-page":"10229","DOI":"10.1038\/s41598-019-46707-6","volume":"9","author":"FH Hung","year":"2019","unstructured":"Hung FH, Wang YA, Jian JW, Peng HP, Hsieh LL, Hung CF, et al. Evaluating BRCA mutation risk predictive models in a Chinese cohort in Taiwan. Sci Rep. 2019;9(1):10229.","journal-title":"Sci Rep"},{"issue":"2","key":"1027_CR54","first-page":"101","volume":"11","author":"DR Youlden","year":"2014","unstructured":"Youlden DR, Cramb SM, Yip CH, Baade PD. Incidence and mortality of female breast cancer in the Asia-Pacific region. Cancer Biol Med. 2014;11(2):101\u201315.","journal-title":"Cancer Biol Med"},{"issue":"2","key":"1027_CR55","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1007\/s10549-011-1596-x","volume":"132","author":"J Zhang","year":"2012","unstructured":"Zhang J, Pei R, Pang Z, Ouyang T, Li J, Wang T, et al. Prevalence and characterization of BRCA1 and BRCA2 germline mutations in Chinese women with familial breast cancer. Breast Cancer Res Treat. 2012;132(2):421\u20138.","journal-title":"Breast Cancer Res Treat"},{"issue":"4","key":"1027_CR56","doi-asserted-by":"publisher","first-page":"357","DOI":"10.4048\/jbc.2013.16.4.357","volume":"16","author":"H Kim","year":"2013","unstructured":"Kim H, Choi DH. Distribution of BRCA1 and BRCA2 mutations in Asian patients with breast cancer. J Breast Cancer. 2013;16(4):357\u201365.","journal-title":"J Breast Cancer"},{"issue":"10","key":"1027_CR57","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1001\/jama.2020.0229","volume":"323","author":"AW Kurian","year":"2020","unstructured":"Kurian AW, Bernhisel R, Larson K, Caswell-Jin JL, Shadyab AH, Ochs-Balcom H, et al. Prevalence of pathogenic variants in cancer susceptibility genes among women with postmenopausal breast cancer. JAMA. 2020;323(10):995\u20137.","journal-title":"JAMA."},{"issue":"D1","key":"1027_CR58","doi-asserted-by":"publisher","first-page":"D944","DOI":"10.1093\/nar\/gkx986","volume":"46","author":"S Song","year":"2018","unstructured":"Song S, Tian D, Li C, Tang B, Dong L, Xiao J, et al. Genome variation map: a data repository of genome variations in BIG data center. Nucleic Acids Res. 2018;46(D1):D944\u20139.","journal-title":"Nucleic Acids Res"},{"key":"1027_CR59","unstructured":"Zhao H. GVM000301. Genome Variation Map. URL: https:\/\/ngdc.cncb.ac.cn\/search\/?dbId=gvm&q=GVM000301. Accessed 11 Jan 2022."},{"key":"1027_CR60","unstructured":"Liu J, Zhao H. The DNA-repair pathway Associated Breast Cancer (DrABC) calculator scripts. Github. URL: https:\/\/github.com\/zhq921\/DrABC. Accessed 20 Dec 2021."}],"container-title":["Genome Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13073-022-01027-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13073-022-01027-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13073-022-01027-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,24]],"date-time":"2022-10-24T22:14:47Z","timestamp":1666649687000},"score":1,"resource":{"primary":{"URL":"https:\/\/genomemedicine.biomedcentral.com\/articles\/10.1186\/s13073-022-01027-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,25]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["1027"],"URL":"https:\/\/doi.org\/10.1186\/s13073-022-01027-9","relation":{},"ISSN":["1756-994X"],"issn-type":[{"value":"1756-994X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,25]]},"assertion":[{"value":"21 December 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 February 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was reviewed and approved by the ethics committees at the Cancer Hospital of Chinese Academy of Medical Sciences and Peking Union Medical College (the main patient source, reference number: 2021041314383902) and other six hospitals, including (1) Huanxing Cancer Hospital, (2) Guiyang Maternal and Child Healthcare Hospital in Guiyang, (3) the Affiliated Cancer Hospital of Zhengzhou University, (4) the Affiliated Yantai Yuhuangding Hospital of Qingdao University, (5) the Fourth Hospital of Hebei Medical University, and (6) Beijing Tiantan Hospital all in China. This study conformed to the principles of the Helsinki Declaration. Written informed consent was obtained from each participant.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Patients in this study gave consent to publish variant information.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"21"}}